CIWT yields 500000.00% · PFE yields 6.20%● Live data
📍 CIWT pulled ahead of the other in Year 1
Combined, CIWT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CIWT + PFE for your $10,000?
China Industrial Waste Management, Inc. provides environmental services and solutions in northeastern China. The company collects, stores, treats, disposes, and recycles industrial solid waste through incineration and/or landfill, physical and/or chemical treatment, material processing, packaging, analysis, and storage. It is also involved in the treatment of municipal sewage, as well as sludge resulting from the processing of sewage that is routed from the sewage treatment facilities located in Dalian and surrounding areas. The company operates a sewage treatment facility and a sludge treatment facility in Dalian, as well as provides environmental pollution remediation services to the Dalian municipal government. In addition, it offers environmental protection, technology consultation, pollution treatment, waste management design processing, waste disposal, waste transportation, and onsite waste management services. The company sells its recycled materials, including cupric sulfate, as well as metals and methane derived from sludge treatment to commodity traders and metallurgical companies. China Industrial Waste Management, Inc. was founded in 1991 and is based in Dalian, China.
Full CIWT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.